Increased secretion of adiponectin can mitigate prepubertal androgen-induced metabolic disorders in dihydrotestosterone-exposed mice with PCOS-like phenotypes (Benrick et al., 2017). This evidence concerns the gene ADIPOQ and polycystic ovary syndrome.